EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

KRAS G12V mutation-selective requirement for ACSS2 in colorectal adenoma formation

Konstantin Budagyan, Alexa C Cannon, Adam Chatoff, Dorothy Benton, Alison M Kurimchak, Daniela Araiza-Olivera, Anastasiia Gerasimova, Nathaniel W Snyder, James S Duncan, Cristina Uribe-Alvarez, Jonathan Chernoff

Cell Reports · 2025-04 · 44 (4) · 115444

DOI: 10.1016/j.celrep.2025.115444 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025-04. Verfasst von Konstantin Budagyan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Molecular Biology, Drexel University College of Medicine, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras), Colorectal Neoplasms, Adenoma, Mutation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins p21(ras)Colorectal NeoplasmsAdenomaMutationAnimalsMiceHumansCell ProliferationCell Line, Tumor

Stichwörter der Autor:innen

ACSS2CP: CancerKRASacetateacetyl-CoAacetylationadenomacolorectal cancerdrug resistancemetabolismsignal transduction

Substanzen

Proto-Oncogene Proteins p21(ras)Hras protein, mouseKRAS protein, human

Autor:innen und Institutionen

  • Department of Biochemistry & Molecular Biology, Drexel University College of Medicine, Philadelphia, PA, USA.
  • Department of Cancer & Cellular Biology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
  • Cancer Signaling & Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Department of Cancer & Cellular Biology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA; Cancer Signaling & Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Cancer Signaling & Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA. Electronic address: cristina.uribe-alvarez@fccc.edu.
  • Cancer Signaling & Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA. Electronic address: j_chernoff@fccc.edu.

Förderung

  • NIGMS NIH HHS
  • NCI NIH HHS
  • National Cancer Institute
  • Harvard Medical School
  • NIH National Institute of General Medical Sciences
  • National Institutes of Health

Zitieren

APA

Budagyan, K., Cannon, A. C., Chatoff, A., Benton, D., Kurimchak, A. M., Araiza-Olivera, D., Gerasimova, A., Snyder, N. W., Duncan, J. S., Uribe-Alvarez, C., & Chernoff, J. (2025). KRAS G12V mutation-selective requirement for ACSS2 in colorectal adenoma formation. Cell Reports, 44(4), 115444. https://doi.org/10.1016/j.celrep.2025.115444

Vancouver

Budagyan K, Cannon AC, Chatoff A, Benton D, Kurimchak AM, Araiza-Olivera D, et al. KRAS G12V mutation-selective requirement for ACSS2 in colorectal adenoma formation. Cell Reports. 2025;44(4):115444. doi:10.1016/j.celrep.2025.115444

BibTeX
@article{Budagyan2025,
  author = {Budagyan, Konstantin and Cannon, Alexa C and Chatoff, Adam and Benton, Dorothy and Kurimchak, Alison M and Araiza-Olivera, Daniela and Gerasimova, Anastasiia and Snyder, Nathaniel W and Duncan, James S and Uribe-Alvarez, Cristina and Chernoff, Jonathan},
  title = {KRAS G12V mutation-selective requirement for ACSS2 in colorectal adenoma formation},
  journal = {Cell Reports},
  year = {2025},
  volume = {44},
  number = {4},
  pages = {115444},
  doi = {10.1016/j.celrep.2025.115444}
}
Kostenlos starten →